Infosys Foundation's Investment in Strengthening Maternity Care

India Pharma Outlook Team | Friday, 23 February 2024

 health monitoring , monitoring technology, India Pharma Outlook

Photo:Representative Image

The Infosys Foundation, the philanthropic and CSR arm of Infosys, has partnered with the Centre for Cellular and Molecular Platforms (C-CAMP), an initiative supported by the Union government's Department of Biotechnology. The foundation will provide Rs. 8.5 crore for the 'C-CAMP-Infosys Foundation Project Early Life,' aimed at improving maternity care in Karnataka using innovative medical technologies for expectant mothers and newborns.

The C-CAMP-Infosys Foundation Project Early Life was launched at the Government of Karnataka's roundtable on health titled 'A new paradigm with CSR and Philanthropy' in partnership with C-CAMP. It aims to address the early adoption of healthcare technology at low-resource health facilities to improve maternal health screening and reduce neonatal mortality rates.

Under this project, advanced fetal monitoring technology will be deployed to enhance the health monitoring of expectant mothers across district hospitals and community health centers in Karnataka. Additionally, neonatal Continuous Positive Airway Pressure devices, which provide respiratory support for newborns in respiratory distress, will be available across critical care newborn units in district and taluk hospitals. This collaboration aims to benefit around 50,000 to 1 lakh women and 4,000 newborns across eight districts in the state over four years.

Dinesh Gundu Rao, Karnataka's health and family welfare minister, said, "Improving maternal and newborn healthcare in the districts is a high priority. We will start with Dharwad and Ballari and cover eight districts to strengthen health monitoring for all mothers and provide quality care to newborns requiring critical care support. I wholeheartedly appreciate C-CAMP and Infosys Foundation for taking this initiative; this program will undoubtedly make quality healthcare accessible to the masses in Karnataka's districts."

Dr. Taslimarif Saiyed, CEO and director of C-CAMP, said, "This initiative furthers our collective endeavor to leverage advanced technology built indigenously to provide quality care to mothers and their newborns and create avenues for affordable and accessible healthcare in Karnataka.

© 2024 India Pharma Outlook. All Rights Reserved.